DIAMEDICA THERAPEUTICS INC

DMAC · NASDAQ

Updated at 2026-10-15 08:07:21

$7.66-2.04%
Today's High
$8.02
Today’s Low
$7.61
DIAMEDICA THERAPEUTICS INC (DMAC) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$7.68
Previous Close
$7.66
Volume
286.96K
Market Cap
$413.07M
P/E Ratio
--
EPS
$-0.71

Previous Day Range

$7.61$8.02

52-Week Range

$5.24$10.41

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
301 CARLSON PARKWAY, MINNEAPOLIS, MN, UNITED STATES, 55305
Country
US
Listing Date
2008-01-04
Fiscal Year End
December
Shares Outstanding
53.88M
CIK
0001401040

DiaMedica Therapeutics Inc., a clinical-stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company is headquartered in Minneapolis, Minnesota.

Financial Metrics

Revenue

2026-06-30

$0

2026-03-31

$0

2025-12-31

-$27.99K

2025-09-30

$0

Operating Expenses

2026-06-30

$10.13M

2026-03-31

$10.48M

2025-12-31

$9.21M

2025-09-30

$9.03M

Net Income

2026-06-30

-$10.13M

2026-03-31

-$10.04M

2025-12-31

-$8.74M

2025-09-30

-$8.62M

Net Profit Margin

2026-06-30

--

2026-03-31

--

2025-12-31

31.21K%

2025-09-30

--

Earnings Per Share

2026-06-30

$-0.19

2026-03-31

$-0.19

2025-12-31

$-0.17

2025-09-30

$-0.17

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$10.12M

2026-03-31

-$10.02M

2025-12-31

-$8.71M

2025-09-30

-$8.59M

Effective Tax Rate

2026-06-30

-0.06%

2026-03-31

0.06%

2025-12-31

-0.11%

2025-09-30

-0.06%

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.